Unique ID issued by UMIN | UMIN000008485 |
---|---|
Receipt number | R000009976 |
Scientific Title | A phase I study of SMP-105 (BCG-CWS) in patients with advanced cancers refractory to the standard treatment |
Date of disclosure of the study information | 2012/07/25 |
Last modified on | 2013/01/24 15:16:18 |
A phase I study of SMP-105 (BCG-CWS) in patients with advanced cancers refractory to the standard treatment
A phase I study of SMP-105 (BCG-CWS)
A phase I study of SMP-105 (BCG-CWS) in patients with advanced cancers refractory to the standard treatment
A phase I study of SMP-105 (BCG-CWS)
Japan |
Malignant tumors
Medicine in general |
Malignancy
NO
To estimate the maximum tolerated dose (MTD), the dose-limiting toxicity (DLT) and the recommended dose (RD) of SMP-105 in patients with advanced cancer refractory to the standard treatment.
Safety
Exploratory
Explanatory
Phase I
Safety: Profile of adverse events, maximum tolerated dose (MTD), dose limiting toxicity (DLT), and recommended dose (RD).
Quality of life (QOL), induction of interferon-gamma, and tuberculin skin test.
Interventional
Parallel
Non-randomized
Open -no one is blinded
Uncontrolled
3
Treatment
Medicine |
Intradermal injection of 50 microgram SMP-105, weekly, four cycles
Intradermal injection of 100 microgram SMP-105, weekly, four cycles
Intradermal injection of 200 microgram SMP-105, weekly, four cycles
20 | years-old | <= |
75 | years-old | >= |
Male and Female
1) Patients with histologically confirmed malignant tumors.
2) Patients with malignant tumors refractory to standard therapy or without any hope of its efficacy.
3) Patients without any prior therapies (surgery, radiotherapy, chemotherapy, hyperthermia, other immunotherapy, and so on) for at least two weeks and without their influence.
4) Patients aged 20 to 75 years old.
5) Patients with at least three-month estimated life expectancy.
6) Patients with ECOG performance status of 0 to 2.
7) Adequate major organ functions and meeting the criteria below:
White blood cell counts >= 3,000/mm3
Absolute neutrophil counts >= 1500/mm3
Platelet counts >= 100,000/mm3
Hemoglobin >= 8.0 g/dL
AST and ALT <= 2 times the upper limit of normal
Serum bilirubin <= 1.5 times the upper limit of normal
Serum creatinine <= 1.5 times the upper limit of normal
No serious abnormal ECG
8) All patients are required to provide written informed consent.
1) Patients with severe complications infectious disease, interstitial pneumonitis, cardiac disease, renal disease, hepatic disease, and uncontrolled diabetes mellitus.
2) Patients with autoimmune disease (scleroderma, Sjogren's syndrome syndrome, idiopathic thrombocytopenic purpura, multiple sclerosis, rheumatoid arthritis, and so on).
3) Patients who need the treatment with corticosteroids and immunesuppressive agents during this study (The use of their local and inhaled administration and non-steroidal anti-inflammatory agents is permitted).
4) Pregnant, lactating, or potentially to be pregnant.
5) Patients judged inappropriate for this study by responsible investigators.
9
1st name | |
Middle name | |
Last name | Kiyoshi Yokokawa |
Kobe Haborland Immunotherapy Clinic
Clinic director
Kobe Harborland Center Building 14F, 1-3-3, Higashi Kawasakimachi, Chuo-ku, Kobe, Hyogo, 650-0044, Japan
078-360-3313
1st name | |
Middle name | |
Last name | Kiyoshi Yokokawa |
Kobe Haborland Immunotherapy Clinic
Clinic director
Kobe Harborland Center Building 14F, 1-3-3, Higashi Kawasakimachi, Chuo-ku, Kobe, Hyogo, 650-0044
078-360-3313
Kobe Haborland Immunotherapy Clinic
NPO the Supporting Center for Clinical Research and Education
Other
NO
神戸ハーバーランド免疫療法クリニック (兵庫県)
堂島リーガクリニック(大阪府)
2012 | Year | 07 | Month | 25 | Day |
Unpublished
Completed
2012 | Year | 06 | Month | 20 | Day |
2012 | Year | 08 | Month | 01 | Day |
2013 | Year | 01 | Month | 21 | Day |
2013 | Year | 01 | Month | 21 | Day |
2013 | Year | 01 | Month | 21 | Day |
2013 | Year | 01 | Month | 21 | Day |
2012 | Year | 07 | Month | 20 | Day |
2013 | Year | 01 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009976
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |